Literature DB >> 576498

Restoration of lung pressure-volume characteristics with surfactant: comparison of nebulization versus instillation and natural versus synthetic surfactant.

M Ikegami, T Hesterberg, M Nozaki, F H Adams.   

Abstract

The pressure-volume (PV) characteristics of 21 adult rat lungs were examined before and after lung washing after which natural or synthetic (dipalmitoyl lecithin (DPL)) surfactant was administered by either an ultrasonic nebulizer or instilled directly into the trachea. Lungs receiving surfactant by nebulization were ventilated at a rate of 40/min at 20 cm H2O peak inspiratory pressure and with 7 cm H2O positive end expiratory pressure (PEEP) for 2 hr. Lungs receiving surfactant by instillation were ventilated for 5 min in a fashion similar to the nebulization study; then a final PV curve was obtained. Results from the deflation limb of the PV curves at 5 and 10 cm H2O were analyzed and expressed as a percentage of the original total lung capacity obtained at 30 cm H2O (percentage of TLC). The control values of percentage of TLC were 52.8 +/- 6.4 at 5 cm H2O and 73.9 +/- 3.9 at 10 cm H2O. Neither nebulization nor instillation of DPL produced a significant increase in percentage of TLC. Nebulization of natural surfactant produced only a slight increase in percentage of TLC from 4.8 +/- 2,4 to 6.7 +/- 2.1 (not significant) at 5 cm H2O and from 21.1 +/- 6.1 to 27.8 +/- 5.4 (P less than 0.05) at 10 cm H2O. Instillation of natural surfactant produced a very striking increase of percentage of TLC from 13.2 +/- 8.0 to 55.6 +/- 4.3 (P less than 0.01) at 5 cm H2O and from 47.9 +/- 6.1 to78.6 +/- 4.2 (P less than 0.01) at 10 cm H2O.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576498     DOI: 10.1203/00006450-197703000-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

Review 1.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

2.  Possible treatment for RDS.

Authors: 
Journal:  Br Med J       Date:  1978-08-12

3.  Factors influencing surfactant composition in the newborn infant.

Authors:  M Obladen
Journal:  Eur J Pediatr       Date:  1978-07-03       Impact factor: 3.183

4.  Lavaged excised rat lungs as a model of surfactant deficiency.

Authors:  M S Bermel; J T McBride; R H Notter
Journal:  Lung       Date:  1984       Impact factor: 2.584

5.  Surfactant substitution; experimental models and clinical applications.

Authors:  B Robertson
Journal:  Lung       Date:  1980       Impact factor: 2.584

6.  Artificial surfactant therapy for hyaline membrane disease.

Authors:  J S Wigglesworth
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

7.  Surfactant substitution.

Authors:  M Obladen; F Brendlein; B Krempien
Journal:  Eur J Pediatr       Date:  1979-08       Impact factor: 3.183

8.  Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.

Authors:  M Ikegami; A Jobe; H Jacobs; S J Jones
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

9.  Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs.

Authors:  C Morley; B Robertson; B Lachmann; R Nilsson; A Bangham; G Grossmann; N Miller
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

10.  Duration and characteristics of treatment of premature lambs with natural surfactant.

Authors:  A Jobe; M Ikegami; T Glatz; Y Yoshida; E Diakomanolis; J Padbury
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.